News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Icahn Drops Suit After Making Nice With Amylin Pharmaceuticals, Inc. (AMLN) CEO


4/26/2012 6:51:23 AM

NEW YORK, April 25, 2012 /PRNewswire/ -- Carl C. Icahn today announced that his affiliates had voluntarily dismissed their lawsuit against Amylin Pharmaceuticals which had sought an extension of the deadline to nominate directors at the 2012 annual meeting of shareholders. Mr. Icahn released the following statement:

The decision to discontinue our lawsuit seeking to extend the director nomination deadline was the result of discussions I had with Daniel Bradbury, Amylin's chief executive officer, that we agreed would not be publicly disclosed.

Mr. Icahn reiterated that he continues to strongly believe that the company should be sold at this time.

SOURCE Carl C. Icahn


Read at BioSpace.com
Read at Bloomberg
Read at Reuters
Read at New York Times
Read at Wall Street Journal

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES